A faster route to eliminating parasitic infection endemic to Africa

In a clinical trial, researchers find moxidectin, a new medicine for river blindness, also works for lymphatic filariasis 

Click on the link to read more : https://medicine.washu.edu/news/a-faster-route-to-eliminating-parasitic-infection-endemic-to-africa/

Philip Budge, MD, PhD (center), an associate professor in the Division of Infectious Diseases at WashU Medicine, speaks with collaborators Benjamin Koudou of the Centre Suisse de Recherches Scientifiques (CSRS) in Côte d'Ivoire (left) and Catherine Bjerum, MD, of Case Western Reserve University. Their recent clinical trial finds the anti-parasitic drug moxidectin — currently approved to treat river blindness, another tropical disease caused by parasitic worms — is also more effective for lymphatic filariasis than the current gold standard, ivermectin. 

https://medicine.washu.edu/